Trastuzumab deruxtecan in patients with active brain metastases from HER2-positive/low metastatic breast cancer: a retrospective multicenter real-world study.

IF 5.6 1区医学 Q1 Medicine

Breast Cancer Research Pub Date : 2025-07-21 DOI:10.1186/s13058-025-02088-5

Fangfang Duan, Xin Hua, Wei Lu, Xingxing Gui, Jingdun Xie, Xudong Wang, Yuyu Ma, Wenyu Zhai, Wen Xia

引用次数: 0

查看原文本刊更多论文

曲妥珠单抗德鲁西替康治疗her2阳性/低转移性乳腺癌脑转移患者：一项回顾性多中心现实世界研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Breast Cancer Research ONCOLOGY-

CiteScore

12.00

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： Breast Cancer Research, an international, peer-reviewed online journal, publishes original research, reviews, editorials, and reports. It features open-access research articles of exceptional interest across all areas of biology and medicine relevant to breast cancer. This includes normal mammary gland biology, with a special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal covers preclinical, translational, and clinical studies with a biological basis, including Phase I and Phase II trials.